Search research articles
Contact Us
Filters
Showing results (51-60 of 99) with videos related to
Page
of 10
Sort By:
Eneuro
|
September 22, 2019
Nuclear Receptor Nr4a1 Regulates Striatal Striosome Development and Dopamine D<sub>1</sub> Receptor Signaling
Maria-Daniela Cirnaru, Chiara Melis, Tomas Fanutza, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 27, 2006
Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors
Jorge M A Oliveira, Sylvia Chen, Sandra Almeida, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 4, 2009
Posttranslational modification of ataxin-7 at lysine 257 prevents autophagy-mediated turnover of an N-terminal caspase-7 cleavage fragment
Shona Mookerjee, Theodora Papanikolaou, Stephan J Guyenet, et al.
Chemistry & Biology
|
November 25, 2010
Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models
Melissa J Leyva, Francesco Degiacomo, Linda S Kaltenbach, et al.
The Journal of Biological Chemistry
|
December 5, 2002
Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity
Frederick C Nucifora, Lisa M Ellerby, Cheryl L Wellington, et al.
Brain : a Journal of Neurology
|
January 24, 2026
Targeting UCHL3 attenuates pathological markers in neuronal models of Huntington's disease
Hasan Ishtayeh, Elena Battistoni, Sharon Pochtar, et al.
Journal of Neuroinflammation
|
March 8, 2024
TYROBP/DAP12 knockout in Huntington's disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration
Jordi Creus-Muncunill, Jean Vianney Haure-Mirande, Daniele Mattei, et al.
Chemical Biology & Drug Design
|
August 3, 2006
Structural evaluation of a novel pro-apoptotic peptide coupled to CNGRC tumor homing sequence by NMR
Cristina M Sandoval, Bernhard H Geierstanger, Satoshi Fujimura, et al.
Neuron
|
July 31, 2010
Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease
John P Miller, Jennifer Holcomb, Ismael Al-Ramahi, et al.
The Journal of Biological Chemistry
|
May 31, 2015
Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in Vivo
Robert O'Brien, Francesco DeGiacomo, Jennifer Holcomb, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 99) with videos related to
Sort By:
Page
of 10
Eneuro
|
September 22, 2019
Nuclear Receptor Nr4a1 Regulates Striatal Striosome Development and Dopamine D<sub>1</sub> Receptor Signaling
Maria-Daniela Cirnaru, Chiara Melis, Tomas Fanutza, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 27, 2006
Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors
Jorge M A Oliveira, Sylvia Chen, Sandra Almeida, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 4, 2009
Posttranslational modification of ataxin-7 at lysine 257 prevents autophagy-mediated turnover of an N-terminal caspase-7 cleavage fragment
Shona Mookerjee, Theodora Papanikolaou, Stephan J Guyenet, et al.
Chemistry & Biology
|
November 25, 2010
Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models
Melissa J Leyva, Francesco Degiacomo, Linda S Kaltenbach, et al.
The Journal of Biological Chemistry
|
December 5, 2002
Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity
Frederick C Nucifora, Lisa M Ellerby, Cheryl L Wellington, et al.
Brain : a Journal of Neurology
|
January 24, 2026
Targeting UCHL3 attenuates pathological markers in neuronal models of Huntington's disease
Hasan Ishtayeh, Elena Battistoni, Sharon Pochtar, et al.
Journal of Neuroinflammation
|
March 8, 2024
TYROBP/DAP12 knockout in Huntington's disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration
Jordi Creus-Muncunill, Jean Vianney Haure-Mirande, Daniele Mattei, et al.
Chemical Biology & Drug Design
|
August 3, 2006
Structural evaluation of a novel pro-apoptotic peptide coupled to CNGRC tumor homing sequence by NMR
Cristina M Sandoval, Bernhard H Geierstanger, Satoshi Fujimura, et al.
Neuron
|
July 31, 2010
Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease
John P Miller, Jennifer Holcomb, Ismael Al-Ramahi, et al.
The Journal of Biological Chemistry
|
May 31, 2015
Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in Vivo
Robert O'Brien, Francesco DeGiacomo, Jennifer Holcomb, et al.
Page
of 10